DC Discussion Group

With the origins of CASSS in mind, the DC Area Scientific Discussion Group offers an opportunity for CASSS members to meet others who understand what they do in an informal setting and exchange new ideas. They have been bringing people in the field of biotechnology and biopharmaceutical development together since 2014. This group’s mission is "Bringing Together Industrial Challenges in the Development of Biologics with Advances in Science and Technology." Anyone in the greater DC/Maryland area (or for virtual meetings, anyone around the world) affiliated with biotechnology, or interested in learning more about the scientific and technological applications to biotechnology is invited to attend. 

mRNA Vaccines: From Discovery to Platform | December 14, 2022 15:00-17:00 EST

We have three significant speakers lined up for an in-depth overview of mRNA vaccines and therapeutics, followed by a panel discussion with live audience participation. You can join from anywhere in the world and participate in real time about this important topic. Registration will close December 12, 2022.

Most people hadn’t heard of mRNA before COVID.  Since their introduction mRNA vaccines have been recognized as a technology which is readily adaptable to different diseases and infections, as well as to rapidly evolving viral variants. Their structure and manufacture resembles something closer to a synthetic small molecule than a biologically generated antigen while protection against historical and new pathogens is just an insertion change away from being a vaccine candidate. This DC Discussion Group session will be dedicated to the discovery and introduction of mRNA to the repertoire of live virus, protein based, polysaccharide, and other genetically based immunogens, and will highlight the opportunity to use platform thinking to facilitate the development and manufacture of vaccine of the future.

Featured Speakers:

Image of female with text 'DCG Featured Speaker Sarita Acharya US Pharmacopeia'Image of male with text 'DCG Featured Speaker Jeff Ulmer GlaxoSmithKline'Image of female with text 'DC Discussion Group Featured Speaker Qi Zeng GlaxoSmitKline'

Ensuring Quality and Safety of mRNA Vaccines Today and Tomorrow

Sarita Acharya, US Pharmacopeia.

The Path to Success for mRNA

Jeff Ulmer, formerly GlaxoSmithKline.

Capping and Poly(A) Tail Analysis for mRNA Vaccine Product Development

Qi Zeng, GlaxoSmithKline.




Virtual Attendees

Watch and participate in this interactive virtual discussion group on December 14, 2022. There is no cost to register. Registration includes access to the live meeting and presenters’ slides. Registration will close December 12, 2022.

Register Now

Register Now

Join us for DC Discussion Group on December 14, 2022. Registration will close December 12, 2022.

Image with text 'casss discussion groups'